• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Marketing II: Indu Isaacs
 

Marketing II: Indu Isaacs

on

  • 1,404 views

 

Statistics

Views

Total Views
1,404
Views on SlideShare
1,196
Embed Views
208

Actions

Likes
0
Downloads
2
Comments
0

6 Embeds 208

http://tieyoungentrepreneurs.blogspot.com 186
http://tieyoungentrepreneurs.blogspot.in 17
http://tieyoungentrepreneurs.blogspot.ca 2
http://bostontye.ning.com 1
http://www.slideshare.net 1
http://tieyoungentrepreneurs.blogspot.de 1

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Marketing II: Indu Isaacs Marketing II: Indu Isaacs Presentation Transcript

    •  
    • About Us
      • Lowell: Wannalancit
      • Focused on Formulation and Analytical Development for Biologics
      • Pre-Formulation/Formulation Development
      • Dosage Form Development
      • Lyophilization Development
      • Analytical Development & Validations
      • Cell Culture Development
      • Purification Development
      Contract Development Services
    • About Us
      • ANDOVER
      • Construction of CGMP Aseptic Fill/Finish facility began in 2000 in Andover
      • CGMP Aseptic Manufacturing suite March 2001
      • 35,000 ft 2 Facility & ~ 75 Staff
      • CGMP Manufacture of Aseptic products for clients in US, Canada, Israel, Australia, NZ, UK, Germany, & Japan.
        • Materials for Toxicological testing
        • Clinical Trials (Phases I, II and III)
      Contract Manufacturing Services
    • Our Experience
      • We have assisted clients with projects in all stages of the regulatory process :
      • Discovery
      • Pre-clinical
      • Clinical
      • Post Approval
    • Corporate Objective
      • Customer Service, Satisfaction, and Loyalty
      • Quality
      • Productivity/Capabilities/Efficiency
    • Our Mission
      • “ Making a Difference”
    • Our Logo
    • Our Motto Doing whatever it takes to build client relationships and ensure repeat business!!!
    • Our Goal: Meeting Expectations
      • Corporate
      • Time-to-Clinic
      • Time-to-Market
      • Agency
      • Consistent Process
      • Stable Dosage Form
    • Our Successes!!
      • FDA inspected GMP Facility May 2003, July 2005 (No 483’s)
      • MHRA inspected & letter of EU GMP compliance (1st in the US) (3 times)
      • 200+ manufacturing clients globally
      • Synagis® and Humira® Development
      • High antibody concentration formulations
      • Orally Bioavailable Peptide in a capsule
      • Solubilization of Insoluble molecules
            • IP Spun off as neu MirR x Corp
    • Our Tag line
      • “ Helping make new drugs happen… at the speed of science”
      • Management Strength and Vision
      • Manufacturing and Development
      • Proven Track Record
      • Strong Global Marketing & Clientele
      Our Strategic Advantage
    • Contract Services Out-License Technology In-License Products The Golden Key Management: Vision
    • PERFORMANCE
    • Performance
    •